Comparing ways to buy Mounjaro online in the UK

You search, you find dozens of sites, here is the single check that filters most of them out

Open the GPhC pharmacy register in a new tab. Every legitimate online pharmacy dispensing prescription medicines in the UK must hold a current GPhC premises registration. Type or paste the registration number from the site you are assessing, and the register confirms instantly whether it is real. That one check, which takes under a minute, rules out the majority of unregistered sellers operating via social media, marketplace listings, and lookalike websites. The MHRA has warned publicly that fake Mounjaro pens have been seized in the UK, with around 20 million doses of illegally traded weight-loss medicines (roughly £45 million street value) removed from circulation, and the first illicit UK site manufacturing counterfeit tirzepatide pens raided in 2025. Prices well below market, offers of supply without a prescription, and sellers with no traceable pharmacy registration are the clearest red flags. You can report a suspect seller directly through the MHRA's Yellow Card scheme. The rest of this page covers what to look for once a provider has cleared that basic test.

The legal route to Mounjaro in the UK, step by step

Mounjaro is a Prescription-Only Medicine. That means a registered prescriber must assess your suitability before any pharmacy may dispense it, this is not a formality that can be waived by any legitimate provider. In practice, the process through a regulated online pharmacy like nume works like this: you complete a clinical questionnaire covering your health history, current medications, and weight; a GPhC-registered Independent Prescriber reads your answers and, if you are clinically suitable, issues a prescription; the pharmacy dispenses from the licensed UK supply chain; and your treatment arrives the next working day in tracked, plain packaging. Identity is verified with photo ID, and weight is confirmed on a live video call, both steps that a compliant prescriber needs to carry out a proper assessment. If you are already on treatment elsewhere and want to transfer, evidence of your current dose is requested before the prescription is written. No shortcuts. That structure is what the GPhC expects, and it is what keeps you safe.

What the comparison between online providers actually turns on

Once you have confirmed a provider holds a valid GPhC registration and genuinely carries out clinical assessment before dispensing, the meaningful differences come down to four things: whether the clinical review is done by a named prescriber or delegated to an algorithm; how quickly the medicine reaches you; what happens after your first pen arrives; and how the total price is structured. Some providers list a low headline price and add consultation fees, prescription charges, and delivery on top. Others include everything but offer little aftercare once you are on treatment. Our Mounjaro provider comparison covers these differences in detail. At nume, one price covers the consultation, prescription, treatment, and free next-working-day delivery, with a prescriber available seven days a week if something comes up. We are not positioned as the cheapest option, a small saving on a prescription medicine is rarely the measure that keeps you safe, and we built the service around the things that matter more.

Am I likely to be eligible, and what does the prescriber assess?

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. Eligibility is not determined by BMI alone: the prescriber reviews your full health picture, including any medicines you take that might interact, any conditions that would make treatment unsuitable, and your goals. How doses are adjusted over time is also something the prescriber discusses from the outset, so you know what to expect, including whether you are likely to begin on the 5mg starting dose or progress toward the 15mg maintenance dose further into treatment. The NICE appraisal of tirzepatide (TA1026) sets the criteria for NHS access, which are considerably stricter than the licensed private eligibility, if you do not meet NHS thresholds or prefer not to wait, a private clinical route is the alternative. If you have questions before starting, our frequently asked questions cover the most common ones, and our support team is available seven days a week.